FDA Approved: REGADENOSON — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved the original ANDA for Regadenoson from Mylan Institutional LLC, enabling a generic version of the vasodilator used in pharmacologic stress testing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

ORIG AP for REGADENOSON (REGADENOSON)